Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052116

CMO and Head of R&D acquired 668,745 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PRASAD SUYASH CMO and Head of R&D 2020-09-23 Grant or award +668,745 668,745 D
Loading xslF345X03/doc4.xml…